You searched for Humanized antibody - Page 32 of 44

Best in Biotech 13 May 2025

Nine biotech companies in Montreal to keep an eye on in 2025

…funding round in 2024 Situated in Montreal, Ability Biotherapeutics has come up with its discovery engine AbiLeap that combines AI and a database of antigen-antibody interactions in order to develop…

May 13, 2025 - 11 minutesmins - By Roohi Mariam Peter

liver fibrosis alentis switzerland cirrhosis cancer

News and Trends 30 Apr 2019

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments….

April 30, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 1 Mar 2017

Swedish Oncology Biotech makes a Large IPO for its Peptides

…Squibb and is the first antibody therapy against multiple myeloma and was approved in May 2016. Moreover, Janssen’s anti-CD38 antibody daratumumab reached its primary endpoint in the first Phase III…

March 1, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 6 Jan 2023

Transgene approved for IV oncolytic virus trial

…powerful antitumor immune response, and a full length anti-CTLA4 antibody. By selectively targeting tumor cells and expressing IL-12 and the anti-CTLA4 antibody in the tumor microenvironment, TG6050 is expected to…

January 6, 2023 - 3 minutesmins - By Jim Cornall

bicycle therapeutics solid tumors trial 1

News and Trends 14 Feb 2018

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

…tumors that express high levels of a molecule called Membrane Type 1 Matrix Metalloproteinase (MT1-MMP). The technology was developed by Greg Winter, who founded Cambridge Antibody Technology, which discovered the…

February 14, 2018 - 3 minutesmins - By Alex Dale

In Depth 22 Dec 2022

10 biotech companies to watch in 2023

…Headquarters: Netherlands As biotech stock markets continued to stagnate in 2022, Argenx was one of the few biotech companies whose stock price increased. The company’s lead drug is an antibody…

December 22, 2022 - 9 minutesmins - By Jonathan Smith

In Depth 1 Sep 2025

Blood Cancer Awareness Month: What biotech holds in store

…That means a therapy aimed at this receptor could hit two birds with one stone, lifting immune suppression while directly targeting the cancer cells. Domain’s antibody, DT-7012, is the first…

September 1, 2025 - 13 minutesmins - By Jules Adam

News and Trends 7 Sep 2022

Could COVID vaccine boosters become obsolete?

…the original strain) are actually very effective in neutralizing the Delta and Omicron variants. According to our findings, the effectiveness of the first antibody, TAU-1109, in neutralizing the Omicron strain…

September 7, 2022 - 5 minutesmins - By Jim Cornall

argenx efgartigimod treatment autoimmune disease myasthenia gravis

News and Trends 21 Dec 2021

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

…marketed as Vyvgart, is an antibody fragment drug for use in adults with generalized myasthenia gravis. The FDA’s decision represents the first successful drug approval for argenx. According to Evaluate…

December 21, 2021 - 4 minutesmins - By Anita Chakraverty

More News! 17 Jul 2024

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

…“The majority of tau pathology, characterized by neurofibrillary tangles in Alzheimer’s disease is intracellular within neurons. This is hard to access with antibody-based treatment approaches. The development of OGA-inhibiting therapies,…

July 17, 2024 - 10 minutesmins - By Jules Adam

News and Trends 13 Mar 2023

New therapy for prevention and treatment of COVID-19

…vivo model. ExeVir Bio’s COVID-19 pipeline includes XVR012, a combination product of the S2-targeting single-domain antibody-based XVR013 reported in the pre-print paper, and XVR014, a bispecific single-domain-based antibody construct that…

March 13, 2023 - 4 minutesmins - By Jim Cornall

In Depth 13 Dec 2024

Is China the future of biotech?

…Chinese companies were biologics. The report notes that the number of antibody drug conjugate (ADC), bispecific antibody, and CAR-T pipelines has increased by seven, five, and four times, respectively. The…

December 13, 2024 - 12 minutesmins - By Jules Adam

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Nine biotech companies in Montreal to keep an eye on in 2025

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Swedish Oncology Biotech makes a Large IPO for its Peptides

Transgene approved for IV oncolytic virus trial

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

10 biotech companies to watch in 2023

Blood Cancer Awareness Month: What biotech holds in store

Could COVID vaccine boosters become obsolete?

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

New therapy for prevention and treatment of COVID-19

Is China the future of biotech?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!